Download PDF
1
/
Pages
Previous article
Go back to website
Next article
If you have problems to see the content please click here
Other users also viewed these articles
The myth of the stigma of fatty liver: What does the evidence show?
Mariana M. Ramírez-Mejía; Xingshun Qi; Ludovico Abenavoli; Nahum Méndez-Sánchez;
10.1016/j.aohep.2024.101535
Insulin resistance and Metabolic dysfunction-associated steatotic liver disease (MASLD): Pathways of action of hypoglycemic agents
Andrea del Carmen Maldonado-Rojas; Julia María Zuarth-Vázquez; Misael Uribe; Varenka J Barbero-Becerra;
Ann Hepatol. 2024;29:
Type 2 diabetes mellitus in metabolic-associated fatty liver disease vs. type 2 diabetes mellitus non-alcoholic fatty liver disease: a longitudinal cohort analysis
Mark Muthiah; Cheng Han Ng; Kai En Chan; Clarissa Elysia Fu; Wen Hui Lim; Darren Jun Hao Tan; Benjamin Nah; Gwyneth Kong; Jieling Xiao; Jie Ning Yong; Bryan Tan; Nicholas Syn; Jiong-Wei Wang; Nilofer Sayed; Eunice Tan; Nicholas WS Chew; Yock Young Dan; Mohammad Shadab Siddiqui; Arun J. Sanyal; Mazen Noureddin;
Ann Hepatol. 2023;28: